BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12633763)

  • 1. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
    Kyriakopoulou LG; Yousef GM; Scorilas A; Katsaros D; Massobrio M; Fracchioli S; Diamandis EP
    Clin Biochem; 2003 Mar; 36(2):135-43. PubMed ID: 12633763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
    Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
    Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V
    J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer.
    Dorn J; Gkazepis A; Kotzsch M; Kremer M; Propping C; Mayer K; Mengele K; Diamandis EP; Kiechle M; Magdolen V; Schmitt M
    Biol Chem; 2014 Jan; 395(1):95-107. PubMed ID: 23999494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.
    Dettmar L; Ahmed N; Kotzsch M; Diersch S; Napieralski R; Darmoul D; Schmitt M; Weichert W; Kiechle M; Dorn J; Magdolen V
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1109-1118. PubMed ID: 29546479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing variant of kallikrein-related peptidase 8 as an independent predictor of unfavorable prognosis in lung cancer.
    Planque C; Choi YH; Guyetant S; Heuzé-Vourc'h N; Briollais L; Courty Y
    Clin Chem; 2010 Jun; 56(6):987-97. PubMed ID: 20360129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer.
    Holzscheiter L; Biermann JC; Kotzsch M; Prezas P; Farthmann J; Baretton G; Luther T; Tjan-Heijnen VC; Talieri M; Schmitt M; Sweep FC; Span PN; Magdolen V
    Clin Chem; 2006 Jun; 52(6):1070-9. PubMed ID: 16627559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.
    Dong Y; Kaushal A; Brattsand M; Nicklin J; Clements JA
    Clin Cancer Res; 2003 May; 9(5):1710-20. PubMed ID: 12738725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma.
    Borgoño CA; Fracchioli S; Yousef GM; Rigault de la Longrais IA; Luo LY; Soosaipillai A; Puopolo M; Grass L; Scorilas A; Diamandis EP; Katsaros D
    Int J Cancer; 2003 Sep; 106(4):605-610. PubMed ID: 12845660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer.
    Yousef GM; Fracchioli S; Scorilas A; Borgoño CA; Iskander L; Puopolo M; Massobrio M; Diamandis EP; Katsaros D
    Am J Clin Pathol; 2003 Mar; 119(3):346-55. PubMed ID: 12645335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
    Tailor PD; Kodeboyina SK; Bai S; Patel N; Sharma S; Ratnani A; Copland JA; She JX; Sharma A
    Oncotarget; 2018 Apr; 9(25):17876-17888. PubMed ID: 29707153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
    Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel overexpression of seven kallikrein genes in ovarian cancer.
    Yousef GM; Polymeris ME; Yacoub GM; Scorilas A; Soosaipillai A; Popalis C; Fracchioli S; Katsaros D; Diamandis EP
    Cancer Res; 2003 May; 63(9):2223-7. PubMed ID: 12727843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.
    Obiezu CV; Scorilas A; Katsaros D; Massobrio M; Yousef GM; Fracchioli S; Rigault de la Longrais IA; Arisio R; Diamandis EP
    Clin Cancer Res; 2001 Aug; 7(8):2380-6. PubMed ID: 11489816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.
    Borgoño CA; Kishi T; Scorilas A; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M; Diamandis EP
    Clin Cancer Res; 2006 Mar; 12(5):1487-93. PubMed ID: 16533772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
    Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP
    Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
    Michaelidou K; Ardavanis A; Scorilas A
    Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies.
    Li X; Liu J; Wang Y; Zhang L; Ning L; Feng Y
    Cancer Sci; 2009 Apr; 100(4):601-7. PubMed ID: 19453546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis.
    Diamandis EP; Borgoño CA; Scorilas A; Yousef GM; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M
    Tumour Biol; 2003; 24(6):299-309. PubMed ID: 15004490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.